Fuxiang Liang

5PUBLICATIONS
20CO-AUTHORS
Innate immunityCharacterisation of biological macromoleculesCancer therapy (excl. chemotherapy and radiation therapy)Proteomics and intermolecular interactions (excl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 04, 2026
GSK'872 mitigates ischemia-reperfusion injury in rat lung transplants by regulating PANoptosis and inflammation in cell type specific manner.

|May 18, 2026
Inherent MS-cleavability of diazirine photo-cross-links enables residue-level structural analysis.

|Dec 21, 2025
Neoadjuvant serplulimab combined with chemotherapy for resectable oesophageal squamous cell carcinoma: a single-arm, phase 2 trial.

Zixiang Wu, Chuanqiang Wu, Youping Wang

|Nov 28, 2025
In-situ cross-linking mass spectrometry reveals compartment-specific proteasomal interactions and structural heterogeneity.

Lili Zhao, Runtao Zhao, Zhou Gong

|Oct 14, 2022
Necrostatin-1 Alleviates Lung Ischemia-Reperfusion Injury via Inhibiting Necroptosis and Apoptosis of Lung Epithelial Cells.

Lingjun Dong, Fuxiang Liang, Zhiling Lou

Pageof 1

Frequent Collaborators

3 joint publications

Ming Wu

2 joint publications

Zhiling Lou

2 joint publications

Yunbi Lu

2 joint publications

Runtao Zhao